Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Fumonisin B1: Oxidative status and DNA damage in rats (CROSBI ID 134074)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Domijan, Ana-Marija ; Želježić, Davor ; Milić, Mirta ; Peraica, Maja Fumonisin B1: Oxidative status and DNA damage in rats // Toxicology, 232 (2007), 3; 163-169-x

Podaci o odgovornosti

Domijan, Ana-Marija ; Želježić, Davor ; Milić, Mirta ; Peraica, Maja

engleski

Fumonisin B1: Oxidative status and DNA damage in rats

Fumonisin B1 (FB1) is a carcinogenic mycotoxin involved in several animal diseases and assumed to be involved in the etiology of some human tumors. FB1 disturbs the metabolism of sphinganine (Sa) and sphingosine (So), increasing the ratio of their concentrations (Sa/So). FB1 is mutagenic in cell cultures, but the mechanism of its genotoxicity is not understood. The aim of this study was to see whether DNA lesions in kidney and liver cells of rats treated with FB1 were related to the changes in the oxidative status or to the disturbance of the sphingolipid metabolism. Male Wistar rats were receiving either FB1 (0.5 mg/kg b.w./day, i.p. for 2 or 7 days) or solvent only and were sacrificed 24 h after the last treatment. The ratio of Sa and So concentrations and parameters of oxidative status (catalytic activity of catalase and the concentrations of protein carbonyls and malondialdehyde, MDA) were measured in plasma and liver and kidney homogenates, while DNA damage was measured in liver and kidney using the comet assay. In plasma and liver and kidney homogenates catalase activity and the concentrations of protein carbonyls and MDA were not affected by the 2-day treatment with FB1, but the ratio of Sa and So in plasma and liver and kidney homogenates was significantly higher than in controls (0.99 &plusmn ; 0.27 versus 0.38 &plusmn ; 0.08, 1.05 &plusmn ; 0.12 versus 0.59 &plusmn ; 0.09 and 4.51 &plusmn ; 0.51 versus 0.54 &plusmn ; 0.17, respectively) (p < 0.05). After the 2-day treatment, the tail length and tail intensity measured with the comet assay in the liver homogenate did not change, while in the kidney homogenate, the difference between the treated and control animals was significant in both the tail length (26.4 &plusmn ; 0.7 &#956; m versus 14.6 &plusmn ; 0.1 &#956; m) and tail intensity (8.0 &plusmn ; 0.4% versus 1.7 &plusmn ; 0.02% DNA) (p < 0.05). After the 7-day treatment all measured parameters significantly differed from controls (p < 0.05). This study showed that FB1 causes DNA lesions in the kidney of experimental animals before affecting the catalytic activity of catalase and the concentration of protein carbonyls and MDA. The ratio of Sa and So significantly increases in all tissues already after 2-day treatment thus indicating that the metabolism of sphingolipids may have an important role in the DNA damage caused by FB1.

catalase; comet assay; malondialdehyde; micronucleus assay; mycotoxins; protein carbonyls

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

232 (3)

2007.

163-169-x

objavljeno

0300-483X

Povezanost rada

Temeljne medicinske znanosti, Biologija

Indeksiranost